Carlos H. Barrios, Gilberto Lopes, Mastura Md Yusof, Fidel Rubagumya et al.
In the past decade, oncologists worldwide have seen unprecedented advances in drug development and approvals but have also become increasingly cognizant of the rising costs of and increasing inequities in access to these therapies. These trends have resulted in the current problematic situation in w...
Ophira Ginsburg, Rajan Badwe, Peter Boyle, Gemma Derrick et al.
Breast and cervical cancer are major threats to the health of women globally, particularly in low-income and middle-income countries. Radical progress to close the global cancer divide for women requires not only evidence-based policy making, but also broad multisectoral collaboration that capitalis...
Marcus Vinícius Oliveira Barros de Alencar, João Marcelo de Castro e Sousa, Hercília Maria Lins Rolim, Maria das Graças Freire de Medeiros et al.
Nowadays, neglected tropical diseases (NTDs) are reported to be present everywhere. Poor and developing areas in the world have received great attention to NTDs. Drug resistance, safety profile, and various challenges stimulate the search for alternative medications. Plant-based drugs are viewed wit...
Chinmay Jani, Samuel A. Kareff, Harpreet Singh, Ana Salazar Zetina et al.
Abstract Introduction: Evolving Lung cancer (LC) trends necessitate a continual reassessment of associated risk factors. Methods: We utilized the Global Burden of Disease database to extract Age-Standardized Mortality Rates (ASMR) and risk factor-associated ASMR for Tracheal, Bronchial, and Lung can...